Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, John Mottershead, Anne‐Louise Ponsonby et al.|Brain|2023Cited by 35
Multiple definitions of PWI-DWI mismatch reliably predict infarct growthKenneth Butcher, Stephen M. Davis, Lachlan MacGregor et al.|Queensland's institutional digital repository (The University of Queensland)|2004Cited by 2
Improvement in Morning Akinesia After Foslevodopa/Foscarbidopa Treatment was Associated with Significantly Improved Motor Fluctuations, Activities of Daily Living, and Quality of Life in People with Parkinson’s Disease (S37.004)Rajesh Pahwa, Angelo Antonini, Sara Dhanani et al.|Neurology|2025Cited by 1
Quality of Life Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa in People with Parkinson’s (P9-3.003)Leonard Verhagen Metman, Jason Aldred, Rajesh Pahwa et al.|Neurology|2024Cited by 0
Improvement in morning akinesia after foslevodopa/foscarbidopa treatment was associated with significantly improved motor fluctuations, activities of daily living, and qualityRajesh Pahwa, Angelo Antonini, Shawkat Dhanani et al.|Parkinsonism & Related Disorders|2025Cited by 0